A significant breakthrough in cancer study is arising with the use of nanobodies to re-engage damaged p53. This vital tumor inhibitor protein is frequently inactivated in several forms of cancer, resulting uncontrolled https://bookmarkfavors.com/story7682988/nanobodies-reactivate-p53-new-potential-hope-for-cancer-management